CN101284108B - Traditional Chinese medicine combination for curing lumbar disease - Google Patents

Traditional Chinese medicine combination for curing lumbar disease Download PDF

Info

Publication number
CN101284108B
CN101284108B CN2008100851183A CN200810085118A CN101284108B CN 101284108 B CN101284108 B CN 101284108B CN 2008100851183 A CN2008100851183 A CN 2008100851183A CN 200810085118 A CN200810085118 A CN 200810085118A CN 101284108 B CN101284108 B CN 101284108B
Authority
CN
China
Prior art keywords
chinese medicine
cervical spondylosis
radix
rhizoma
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008100851183A
Other languages
Chinese (zh)
Other versions
CN101284108A (en
Inventor
李俊海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2008100851183A priority Critical patent/CN101284108B/en
Publication of CN101284108A publication Critical patent/CN101284108A/en
Application granted granted Critical
Publication of CN101284108B publication Critical patent/CN101284108B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese traditional medicinal oral composition for treating cervical spondylosis. The composition contains milk vetch, lopseed, clematis root, Chinese wild ginger, chuanxiong rhizome, angelica, dragon's blood, ground beetle, notoginseng, frankincense and myrrh, and is effective in restoring channels and collaterals, promoting blood circulation, eliminating blood stasis, improving ligament stiffness to enhance annulus fibrosus and completely nourishing cartilage with the blood so as to heal cervical spondylosis.

Description

A kind of Chinese medicine composition for the treatment of cervical spondylosis
Technical field:
The present invention relates to a kind of Chinese medicine composition, particularly a kind of Chinese medicine composition for the treatment of cervical spondylosis.
Background technology:
Cervical spondylosis is a kind of commonly encountered diseases and frequently-occurring disease, obstinate refractory.Cause work, spirit to be had a strong impact on.Reason: because have a cold outward, posture is bad, injure anti-weight outward causes fibrous ring impaired, blood fortune is obstructed, meridians are not smooth, ligament fatigue, cervical muscle is stiff and form.
The Therapeutic Method of cervical spondylosis mainly contains: Chinese medicine, Western medicine, massage, traction, operation etc.Though postponing the state of an illness, Western medicine can not reach the purpose of effecting a permanent cure; Operative treatment has a big risk, expense height, easily recurrence; Though traction massage can respite symptom, can not reach the purpose of radical cure.
Summary of the invention:
The object of the present invention is to provide a kind of the meridian dredging blood circulation promoting and blood stasis dispelling that can relax, improve that ligament is stiff to cause that fibrous ring is dashed and strong, make cartilage obtain fully that the blood profit is supported and the purpose tested recipe that reaches healing.
The Chinese medicine composition of treatment cervical spondylosis of the present invention is mainly made by following raw medicaments in portion by weight:
Radix Astragali 30--150 Herba speranskiae tuberculatae 36--85 Radix Clematidis 45--160 Herba Asari 15-45
Rhizoma Curcumae Longae 25-75 Rhizoma Chuanxiong 45--140 Radix Angelicae Sinensis 40-125 Sanguis Draxonis 60--180
Eupolyphaga Seu Steleophaga 40--160 Radix Notoginseng 80-180 Olibanum 30--155 Myrrha 30-65.
Its crude drug can also comprise: Rhizoma Corydalis 40-80.
Its crude drug can also comprise: Rhizoma Gastrodiae 40-160 Agkistrodon 100--300 Scorpio 20--45 Squama Manis 60--250.
Cross 120 order sieve sieve mixing after can going earth to shine dry grinding after the above-mentioned raw materials medicine is assorted, directly encapsulated or with Mel pill or powder, also can go earth to shine dry grinding, after the water extract-alcohol precipitation extraction, technology is made peroral dosage form routinely.
Be to be monarch with the Radix Astragali in the process of this traditional Chinese medicine composition for treating cervical spondylosis, medicine carrying is up; Herba speranskiae tuberculatae, Radix Clematidis, Herba Asari, Rhizoma Curcumae Longae are minister with the deep blood stasis dispelling of expelling wind and cold; It is assistant with Rhizoma Chuanxiong, Chinese angelica blood supplementing that hyperosteogeny of cervical vertebra makes spinal canal stenosis cause the cerebral blood supply insufficiency event; Sanguis Draxonis, Eupolyphaga Seu Steleophaga, Radix Notoginseng, Olibanum, Myrrha are invigorated blood circulation promoting the circulation of blood for treating the medicine of traumatic injury, stagnation of blood stasis; Herba speranskiae tuberculatae, Radix Clematidis not only go the numbness of meridians, and so the wind that more goes to the joint is for making; The Rhizoma Corydalis mark that the promoting the circulation of QI pain relieving is cured the disease of invigorating blood circulation; Rhizoma Gastrodiae, Agkistrodon, Scorpio, Squama Manis dispel the wind with the meridian dredging will product for what control limbs contracture, tetanic pain, numb limbs and tense tendons, help all medicines to reach the purpose for the treatment of both the principal and secondary aspects of a disease and do not have any negative interaction with ginseng.
The specific embodiment:
Embodiment one: get crude drug Radix Astragali 30g Herba speranskiae tuberculatae 36g Radix Clematidis 45g Herba Asari 15g Rhizoma Curcumae Longae 25g Rhizoma Chuanxiong 45g Radix Angelicae Sinensis 40g Sanguis Draxonis 60g Eupolyphaga Seu Steleophaga 40g Radix Notoginseng 80g Olibanum 30g Myrrha 30g,
Cross 120 order sieve sieve mixing after going earth to shine dry grinding after medicine is assorted, directly encapsulated or with Mel pill or powder.
Embodiment two: get crude drug Radix Astragali 150g Herba speranskiae tuberculatae 85g Radix Clematidis 160g Herba Asari 45g Rhizoma Curcumae Longae 75g Rhizoma Chuanxiong 140g Radix Angelicae Sinensis 125g Sanguis Draxonis 180g Eupolyphaga Seu Steleophaga 160g Radix Notoginseng 180g Olibanum 155g Myrrha 65g,
Cross 120 order sieve sieve mixing after going earth to shine dry grinding after medicine is assorted, directly encapsulated or with Mel pill or powder.
Embodiment three: get crude drug Radix Astragali 90g Herba speranskiae tuberculatae 60g Radix Clematidis 110g Herba Asari 30g Rhizoma Curcumae Longae 55g Rhizoma Chuanxiong 95g Radix Angelicae Sinensis 85g Sanguis Draxonis 120g Eupolyphaga Seu Steleophaga 110g Radix Notoginseng 120g Olibanum 80g Myrrha 50g,
Go earth to shine dry grinding after medicine is assorted, after water extract-alcohol precipitation extracted, technology was made peroral dosage form routinely.
Embodiment four: get crude drug Radix Astragali 100g Herba speranskiae tuberculatae 50g Radix Clematidis 100g Herba Asari 40g Rhizoma Curcumae Longae 45g Rhizoma Chuanxiong 90g Radix Angelicae Sinensis 80g Sanguis Draxonis 110g Eupolyphaga Seu Steleophaga 100g Radix Notoginseng 100g Olibanum 60g Myrrha 40g, and Rhizoma Corydalis 40g,
Go earth to shine dry grinding after medicine is assorted, after water extract-alcohol precipitation extracted, technology was made peroral dosage form routinely.
Embodiment five: get crude drug Radix Astragali 140g Herba speranskiae tuberculatae 70g Radix Clematidis 120g Herba Asari 40g Rhizoma Curcumae Longae 40g Rhizoma Chuanxiong 80g Radix Angelicae Sinensis 60g Sanguis Draxonis 60g Eupolyphaga Seu Steleophaga 50g Radix Notoginseng 100g Olibanum 40g Myrrha 45g, and Rhizoma Corydalis 80g,
Go earth to shine dry grinding after medicine is assorted, after water extract-alcohol precipitation extracted, technology was made peroral dosage form routinely.
Embodiment six: get crude drug Radix Astragali 30g Herba speranskiae tuberculatae 36g Radix Clematidis 45g Herba Asari 15g Rhizoma Curcumae Longae 25g Rhizoma Chuanxiong 45g Radix Angelicae Sinensis 40g Sanguis Draxonis 60g Eupolyphaga Seu Steleophaga 40g Radix Notoginseng 80g Olibanum 30g Myrrha 30g Rhizoma Corydalis 50g Rhizoma Gastrodiae 40g Agkistrodon 100g Scorpio 20g Squama Manis 60g.
Cross 120 order sieve sieve mixing after going earth to shine dry grinding after medicine is assorted, directly encapsulated or with Mel pill or powder.
Embodiment seven: get crude drug Radix Astragali 100g Herba speranskiae tuberculatae 50g Radix Clematidis 100g Herba Asari 40g Rhizoma Curcumae Longae 45g Rhizoma Chuanxiong 90g Radix Angelicae Sinensis 80g Sanguis Draxonis 110g Eupolyphaga Seu Steleophaga 100g Radix Notoginseng 100g Olibanum 60g Myrrha 40g, Rhizoma Corydalis 40g Rhizoma Gastrodiae 160g Agkistrodon 300g Scorpio 45g Squama Manis 250g
Go earth to shine dry grinding after medicine is assorted, after water extract-alcohol precipitation extracted, technology was made peroral dosage form routinely.
Below the example of testing of clinical cure is further set forth the present invention:
(the famous rural traditional Chinese medical science of southern Hebei, the people claims the living immortal to this proved recipe, two Mr.s by grandfather Cai Wenan.) pass on from one to another.The Most patients clinical effectiveness is fine.But there have the small number of patients disease to alleviate to be slower, and individual patient is taken the back DeGrain.After I form according to a tree name clinical experience improvement for many years.Now existing thousands of routine patients take, effective percentage a hundred per cent, and cure rate is more than 90 percent.This medicine is pure Chinese herbal and crude drugs preparations, does not have any negative interaction and harmful effect.
Medical record
1. Chengan County Bao Zhuan people from village of 51 years old Hebei province of the woman of Yang Yu. in 2003 cervical spondylosis, symptom is: uncomfortable in chest, chest pain, if any object compressing, nape aching.DeGrain after county hospital is with western medicine.With the pharmaceutical composition of the embodiment of the invention 1 after seven days symptom obviously alleviate, fully recover after the bimester of taking, recover normal through the examination in hospital cervical vertebra, do not have recurrence so far.
2. the strong man of Cai Wen 21 years old Hebei Cai Zhuan people from village, Guangping County.Symptom is: the extremity flaccidity is soft unable, can't take care of oneself.Be diagnosed as cervical vertebra 3-5 joint hypertrophy through hospital, pressuring nerve institute extremely.With pharmaceutical composition remission after more than ten day of the embodiment of the invention three, take this medicine and fully recover after three months, follow up a case by regular visits to after 18 months and do not have recurrence.
3. people from Nanchang of 36 years old Jiangxi Province of the equal brightness of clock.Suffer from cervical spondylosis for many years, cervical region is ached, and right hand numbness is unable, dizziness headache.The twisting neck period of the day from 11 p.m. to 1 a.m is chuckleed and is made a sound.Introduce through friend, remission behind the pharmaceutical composition first quarter moon of the clothes embodiment of the invention two, recovery from illness after four months checks that through hospital's film making cervical vertebra recovers normal.
4. road 54 years old people from Changchun of Lin Nan that shake.Got cervical spondylosis more than 20 year.Symptom is consequent, sound is done in the stiff twisting of aching pain in should and back, headache and dizzy, both hands numbness, myasthenia of limbs.Be diagnosed as cervical vertebra 2--7 joint hypertrophy through Changchun hospital CT examination, the physiology curvature does not have, through the traction massage poor effect of taking medicine.Introduce pharmaceutical composition remission after more than 20 day of taking the embodiment of the invention five through friend.Take three months all diseases continuously and disappear entirely, do not have recurrence so far.
5. 37 years old people from Guangzhou of Qiao Meimei woman.Cervical region is ached, dizziness headache, blurred vision.Be diagnosed as cervical vertebra 3--5 joint hypertrophy, spinal canal stenosis, cerebral blood supply insufficiency through hospital.Introduce the pharmaceutical composition first quarter moon remission of taking the embodiment of the invention seven through friend, after two months recovery from illness.Be diagnosed as through examination in hospital and return to one's perfect health.

Claims (5)

1. Chinese medicine composition for the treatment of cervical spondylosis, mainly make by following raw medicaments in portion by weight:
Radix Astragali 30-150 Herba speranskiae tuberculatae 36-85 Radix Clematidis 45-160 Herba Asari 15-45
Rhizoma Curcumae Longae 25-75 Rhizoma Chuanxiong 45-140 Radix Angelicae Sinensis 40-125 Sanguis Draxonis 60-180
Eupolyphaga Seu Steleophaga 40-160 Radix Notoginseng 80-180 Olibanum 30-155 Myrrha 30-65.
2. the Chinese medicine composition of treatment cervical spondylosis as claimed in claim 1, its crude drug also comprises: Rhizoma Corydalis 40-80.
3. the Chinese medicine composition of treatment cervical spondylosis as claimed in claim 2, its crude drug also comprises: Rhizoma Gastrodiae 40-160 Agkistrodon 100-300 Scorpio 20-45 Squama Manis 60-250.
4. as the Chinese medicine composition of each described treatment cervical spondylosis of claim 1-3, it is characterized in that: be peroral dosage form.
5. the Chinese medicine composition of treatment cervical spondylosis as claimed in claim 4 is characterized in that: dosage form is capsule, pill or powder.
CN2008100851183A 2008-03-20 2008-03-20 Traditional Chinese medicine combination for curing lumbar disease Expired - Fee Related CN101284108B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2008100851183A CN101284108B (en) 2008-03-20 2008-03-20 Traditional Chinese medicine combination for curing lumbar disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2008100851183A CN101284108B (en) 2008-03-20 2008-03-20 Traditional Chinese medicine combination for curing lumbar disease

Publications (2)

Publication Number Publication Date
CN101284108A CN101284108A (en) 2008-10-15
CN101284108B true CN101284108B (en) 2010-12-08

Family

ID=40056663

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008100851183A Expired - Fee Related CN101284108B (en) 2008-03-20 2008-03-20 Traditional Chinese medicine combination for curing lumbar disease

Country Status (1)

Country Link
CN (1) CN101284108B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102258699A (en) * 2011-08-23 2011-11-30 冯根源 Chinese patent medicament for treating cervical spondylosis and cranial nerve vascular diseases and preparation method thereof

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105816817A (en) * 2016-05-18 2016-08-03 亳州市永博保健食品有限公司 Traditional Chinese medicine composition for treating cervical spondylosis
CN112915183A (en) * 2019-12-05 2021-06-08 北京杨家强骨病中医研究院南京分院 Medicinal blanket for treating thoracolumbar pain and using method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1424024A (en) * 2001-10-23 2003-06-18 罗明新 External used paste for orthopedic diseases
CN1817366A (en) * 2005-11-04 2006-08-16 纪冠军 Medicinal composition for treating rheumatosis and preparation thereof
CN1966042A (en) * 2006-09-22 2007-05-23 任景全 Externally applied ointment for treating hyperosteogeny and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1424024A (en) * 2001-10-23 2003-06-18 罗明新 External used paste for orthopedic diseases
CN1817366A (en) * 2005-11-04 2006-08-16 纪冠军 Medicinal composition for treating rheumatosis and preparation thereof
CN1966042A (en) * 2006-09-22 2007-05-23 任景全 Externally applied ointment for treating hyperosteogeny and preparation method thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
关志宇,等.活血止痛胶囊处方考证及研究进展.食品与药品.2006,8(02),17-21.
关志宇等.活血止痛胶囊处方考证及研究进展.食品与药品.2006,8(02),17-21. *
黄涛,等.中医药治疗神经根型颈椎病进展概况.长春中医学院学报.2001,17(2),56-57.
黄涛等.中医药治疗神经根型颈椎病进展概况.长春中医学院学报.2001,17(2),56-57. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102258699A (en) * 2011-08-23 2011-11-30 冯根源 Chinese patent medicament for treating cervical spondylosis and cranial nerve vascular diseases and preparation method thereof

Also Published As

Publication number Publication date
CN101284108A (en) 2008-10-15

Similar Documents

Publication Publication Date Title
CN102091295B (en) Chinese medicinal composition for treating femoral head necrosis and preparation method thereof
CN101361872A (en) Traditional Chinese medicine for quickly treating bone fracture and postoperative nonunion and delayed healing
CN103006951A (en) Chinese medicinal composition for treating cervical spondylosis and lumbar spondylosis
CN103230488A (en) Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis
CN100556427C (en) The medicine of treatment rheumatism, rheumatoid arthritis
CN100998656A (en) Medicated wine for tonifying bone and removing obstruction in channels
CN103263659A (en) Traditional Chinese medicine composition for treating rheumatism bone diseases
CN101450197B (en) Traditional Chinese medicine for treating rheumatism, rheumatoid disease
CN101284108B (en) Traditional Chinese medicine combination for curing lumbar disease
CN101703662B (en) Oral Chinese medicament for treating hyperosteogeny
CN103301326B (en) Medicament for treating rheumatism, rheumatoid and pain or rheumatism in lower extremities and waist
CN106692548A (en) Medicine for treating scapulohumeral periarthritis and preparation method thereof
CN100344318C (en) Medicine for treating apoplectic sequel and prepn. thereof
CN101411799B (en) Oral medicinal liquor for treating rheumatism and rheumatoid disease
CN102302578A (en) Medicament capable of eliminating dampness and relieving numbness and preparation method thereof
CN101284087B (en) Medicinal composition for curing lumbar disease
CN1839974B (en) Medicine composition for treating rheumatoid disease and method for preparing the same
CN102861220A (en) Traditional Chinese medicine for treating heart disease
CN103157084A (en) Drug for treating osteoporosis
CN100512867C (en) Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia
CN102188688A (en) Traditional Chinese medicine capable of treating cervical and lumbar vertebra hyperosteogeny
CN101874861B (en) Medicament for treating and preventing heart diseases
CN1095369C (en) Hantongling capsule for treatment of wind-cold and wind-dampness syndrome
CN103385944A (en) Formula for osteoproliferation and application method thereof
CN102755437A (en) Plaster for treating scapulohumeral periarthritis

Legal Events

Date Code Title Description
C57 Notification of unclear or unknown address
DD01 Delivery of document by public notice

Addressee: Li Junping

Document name: Notification of Passing Preliminary Examination of the Application for Invention

Addressee: Li Junping

Document name: Notification that Application Deemed not to be Proposed

C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101208

Termination date: 20110320